# How to avoid the most expensive AI mistakes mid-market firms make Avoid costly AI mistakes mid-market firms make. A practical guide for CFOs, COOs and CTOs on sequencing, readiness and governance. From Rodan Analytics. Published: 2025-07-21 Author: Rodan Analytics Most mid-market firms do not have an AI problem. They have a sequencing problem. The board has approved a budget. A vendor has been selected. A pilot is running. And somewhere in that chain, nobody asked whether the underlying data is clean enough to learn from, whether the use case connects to a measurable commercial outcome, or whether the organisation has the capability to operationalise what the pilot produces. The result is predictable: six to eighteen months later, a proof of concept sits on a shelf. The business case looks thinner than it did. The appetite for the next attempt is lower. And the cost — not just in spend, but in lost time and eroded trust — is real. The mistake most organisations at this stage make is treating AI adoption as a technology decision rather than a commercial one. It is not. It is a resource allocation decision, with a sequencing problem at its core. This article gives senior leaders a clear view of where mid-market AI investment goes wrong, and what to do instead. --- ## The pilot that goes nowhere The most common and costly mistake is the pilot that produces no production system. A manufacturer in the £700m revenue range pilots a demand forecasting model. The results in the test environment are strong — 15% improvement on forecast accuracy against the holdout dataset. The data science team is proud of it. Then the question arrives: who owns the integration into the ERP? Who retrains the model when the data drifts? Who changes the planning process to actually use the output? Nobody owns those questions. The pilot ends. The model does not deploy. This is not a technology failure. It is a governance failure that was locked in before the pilot started. The fix is straightforward, but it requires discipline at the point of commissioning rather than at the point of delivery. Before approving any AI initiative, a senior leader should be able to answer four questions: - What decision does this change, and who currently makes that decision? - What does the production system look like, and who operates it? - What is the success metric, and over what time horizon? - What is the exit criteria if it does not perform? If those questions do not have answers before the work starts, the pilot is not a pilot — it is a research project with a budget attached. --- ## Buying capability before you have built readiness The second expensive mistake is purchasing AI capability — platforms, licences, tooling — before the organisation is ready to use it. Enterprise AI software vendors are skilled at selling to the aspiration rather than the current state. A CFO sees a compelling demo. The commercial terms look favourable at scale. The deal gets signed. Twelve months later, utilisation is low, the internal team does not have the skills to configure it properly, and the renewal conversation is uncomfortable. AI readiness is not a binary state. It is a spectrum across four dimensions: data quality and accessibility, technical infrastructure, commercial process maturity and internal capability. Most mid-market firms score unevenly across these. They may have reasonable infrastructure but fragile data pipelines. They may have a capable analytics team but no one who can translate model output into operational decisions. A practical readiness assessment should be honest about where each dimension sits before any vendor conversation begins. The outcome of that assessment should drive the sequencing of investment — not the other way around. Rodan's AI readiness diagnostics are designed exactly for this moment. A structured engagement, typically completed in four to six weeks, that produces a clear view of where the organisation sits across those four dimensions and a prioritised roadmap for what to invest in first. The diagnostic is the thing that makes the subsequent investment defensible. --- ## Centralising too early — or not at all The question of where AI capability should sit inside the organisation trips up mid-market firms in two opposite directions. Some centralise too early. They create a Centre of Excellence, hire a team of data scientists, and wait for the business to bring them problems. The business, predictably, does not engage at the rate expected. The CoE produces technically competent work that lands without commercial context. Stakeholders stop commissioning it. Others never centralise at all. AI initiatives proliferate across functions. Finance runs its own tool. Marketing runs a different one. Operations has a third. Data definitions diverge. Vendor relationships fragment. The firm ends up with six separate monthly subscription costs, three overlapping datasets and no institutional knowledge of what is actually working. Neither structure is wrong in principle. Both are wrong without a clear operating model to go with them. For a firm in the £500m to £1.5bn range, the right structure is usually a small central capability — three to five people — that sets standards, manages vendor relationships and owns the data platform, combined with embedded analytical capability inside the two or three functions where AI has the highest commercial leverage. That hybrid model avoids the ivory tower problem without losing the coherence that centralisation provides. The functions where AI typically has the highest leverage at this revenue scale are commercial (pricing, churn, pipeline forecasting), supply chain and operations (demand planning, cost modelling) and finance (FP&A automation, working capital optimisation). The right sequencing is to build and prove the model in one of those functions before expanding. --- ## Mistaking automation for intelligence A subtler but genuinely costly mistake is deploying AI to automate a broken process rather than to improve a good one. A professional services firm automates its client reporting process using an LLM-enabled workflow. The reports go out faster. The partners are pleased. Six months in, it becomes clear that the underlying data feeding those reports has always been inconsistent — different teams have been defining key metrics differently for years. The automation has made the inconsistency faster and more visible, not less. AI amplifies what is already there. It does not fix what was already wrong. This is particularly relevant for firms considering tools like Quantsole — Rodan's LLM-enabled business intelligence platform — for commercial reporting. The natural language query layer and automated insight generation are genuinely powerful capabilities. But they sit on top of data that needs to be coherent before the intelligence layer adds value. A firm that deploys BI automation on top of fragmented, poorly governed data will get fast answers to the wrong questions. The diagnostic question is simple: if you ran this process manually with perfect execution, would the output be commercially useful? If the answer is no, fix the process first. --- ## What this costs when you get it wrong The direct costs of failed AI programmes are visible: vendor spend, consultant fees, internal time. A mid-market firm that runs two or three failed pilots before finding a working model might spend £1.5m to £3m reaching a point that a better-sequenced investment would have reached for a third of that. The indirect costs are harder to measure but often larger. Trust in data deteriorates. The board's confidence in the technology team drops. The appetite for the next initiative is lower. Talented people leave because they are frustrated by the gap between what they were hired to do and what the organisation will actually commit to. The firms that get AI right at this scale share one characteristic: they treated the first serious investment as a way to build the capability to invest better next time, not just to solve the immediate problem. That orientation — building institutional capability alongside solving a specific problem — is the difference between an organisation that compounds its AI advantage over time and one that runs a series of disconnected pilots indefinitely. If you are in the planning stages of a significant AI investment, the right first step is not a vendor briefing. It is a clear-eyed assessment of what your organisation can actually execute. Rodan's diagnostic engagement is built for that conversation. [Book a diagnostic with Rodan](https://rodan.io) --- **Meta description:** Avoid costly AI mistakes mid-market firms make. A practical guide for CFOs, COOs and CTOs on sequencing, readiness and governance. From Rodan Analytics. HTML: https://rodan.io/insights/how-to-avoid-the-most-expensive-ai-mistakes-mid-market-firms-make